EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities

Huayan Li iD, Xiying He iD, Ting Cao, Jinfeng Huang, Bojun Chen, Lijing Xu, Yanxiao Yang, Gang Li, Lei Xiong

Pharmaceuticals · 2026-08-12 · 19 (8) · 1275

DOI: 10.3390/ph19081275 ↗

At a glance

Übersichtsarbeit in Pharmaceuticals, published online on 2026-08-12. Written by Huayan Li and 8 co-authors. Institution: The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming 650500, China. 168 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Yunnan Province Science and Technology Department.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Depression is a leading cause of disability worldwide, and currently available antidepressants are limited by delayed therapeutic onset, inadequate efficacy in some patients, and adverse effects. G protein-coupled receptors (GPCRs), the largest family of membrane receptors in the central nervous system, regulate neurotransmission, neuroplasticity, neuroinflammation, stress responses, and reward processing, and are therefore important targets for antidepressant drug development. Natural products are a rich source of structurally diverse bioactive compounds, many of which show antidepressant-like effects through the modulation of GPCR-mediated signaling pathways. In this narrative review, we summarize the roles of major GPCR families implicated in depression and provide an updated overview of natural products that modulate these receptors. We particularly emphasize receptor-specific mechanisms, downstream signaling networks, and the pharmacological actions of representative natural compounds. We also highlight emerging concepts in GPCR biology, including receptor heteromerization, signaling bias, and allosteric modulation, that may create new opportunities for antidepressant discovery. Finally, we discuss current challenges related to target validation, pharmacokinetics, and clinical translation. Collectively, these insights support further investigation of natural product-derived GPCR modulators as potential leads for next-generation antidepressant development.

Subjects

Author keywords

G protein-coupled receptorsantidepressant drug discoverycannabinoid receptorsdepressionmedicinal chemistrynatural productsneuroinflammationserotonin receptorssignaling pathways

Authors and institutions

  • The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • The Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming 650500, China.

ORCID profiles: Huayan Li, Xiying He

Funding

  • National Natural Science Foundation of China
  • Yunnan Province Science and Technology Department

Cite

APA

Li, H., He, X., Cao, T., Huang, J., Chen, B., Xu, L., Yang, Y., Li, G., & Xiong, L. (2026). Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities. Pharmaceuticals, 19(8), 1275. https://doi.org/10.3390/ph19081275

Vancouver

Li H, He X, Cao T, Huang J, Chen B, Xu L, et al. Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities. Pharmaceuticals. 2026;19(8):1275. doi:10.3390/ph19081275

BibTeX
@article{Li2026,
  author = {Li, Huayan and He, Xiying and Cao, Ting and Huang, Jinfeng and Chen, Bojun and Xu, Lijing and Yang, Yanxiao and Li, Gang and Xiong, Lei},
  title = {Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {8},
  pages = {1275},
  doi = {10.3390/ph19081275}
}
Start for free →